Results 21 to 30 of about 113,627 (49)
Research progress of artificial intelligence in moyamoya disease
Moyamoya disease (MMD), a chronic, progressive cerebrovascular disorder of unknown etiology, presents significant diagnostic and therapeutic challenges in clinical practice.
Huimin Huang +4 more
doaj +1 more source
Switch from fingolimod to ozanimod for safety or intolerance reasons
Introduction: Ozanimod is a new-generation sphingosine-1-phosphate (S1P) modulator, approved for the treatment of multiple sclerosis (MS), offering higher selectivity for S1P receptor 1 and 5 (SPR1-5), minimizing potential safety concerns related to S1P3
Elisabetta Signoriello +7 more
doaj +1 more source
Sphenopalatine ganglion stimulation for the treatment of trigeminal neuropathic pain
IntroductionUnlike idiopathic trigeminal neuralgia, which can be treated with conventional neurosurgical methods such as microvascular decompression, radiofrequency rhizotomy of the Gasser ganglion, or stereotactic radiosurgery, trigeminal neuropathic ...
Paweł Sokal +7 more
doaj +1 more source
ObjectiveTo investigate whether Tuina therapy alleviated inflammation and motor neuron apoptosis in sciatic nerve injury (SNI) rats by regulating cytosolic phospholipase A2 (cPLA2) and Ras homolog family member A/Rho-associated coiled-coil comprising ...
Jiawei Sun +9 more
doaj +1 more source
Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects
IntroductionTauopathies, including Alzheimer’s disease (AD), feature abnormal accumulations of hyperphosphorylated Tau protein; however, their biomarker potential in traumatic brain injury (TBI) is not well-defined.
Hamad Yadikar +30 more
doaj +1 more source
BackgroundMigraine is a chronic neurological disorder associated with a variety of abnormal visual symptoms. However, the mechanisms of visual processing in migraine are not fully understood.
Di Wu +6 more
doaj +1 more source
IntroductionTo date, disease-modifying therapies have not been established for Parkinson’s disease (PD) or atypical parkinsonisms. Exercise has been reported to help maintain functional abilities and delay disease progression.
Hikaru Kamo +20 more
doaj +1 more source
IntroductionStroke is a leading cause of long-term disability worldwide. Chronic stroke survivors experience gait and balance impairments, limiting mobility and increasing fall risk.
Seung-Hyeon Han +8 more
doaj +1 more source
Biomarkers in spinal muscular atrophy
Spinal muscular atrophy is a hereditary disorder leading to severe neuromuscular impairment. With the introduction of disease-modifying therapies in recent years, the role of biomarkers has expanded from aiding diagnosis to monitoring treatment responses,
Liping Yan +3 more
doaj +1 more source
Biomarkers and therapeutic targets in early Alzheimer’s disease: an Olink proteomics study
PurposeThis study aims to analyze differential expression of inflammation-related proteins in plasma from patients with mild cognitive impairment (MCI) and early-stage Alzheimer’s disease (AD), for exploring potential biomarkers and therapeutic targets ...
Jianan Wei +8 more
doaj +1 more source

